Pharmaceutical Technology's In the Lab eNewsletter 08-05-2020

The use of analytical assays is crucial for determining that biosimilar critical quality attributes remain on point.

This method is expected to help bring gene therapies to market faster, safer, and cheaper.

The investment will allow for the expansion of analytical R&D efforts and will support the company’s reference materials business.

The company’s SLIM technology has been a part of the company’s accelerated growth by offering enhanced R&D analytics.

The company has launched a residual GMP-compliant test and dual sourcing opportunity designed to increase compliance and reduce risks for ATMP manufacture.

The printers can print text, graphics, logos, and 2D bar codes directly onto slides and cassette.

The company has begun development of a 3D bioreactor for the cGMP production of extracellular vesicle exosomes.

A study in published in Scientific Reports showed that researchers were able measure vaccine inactivation by quantifying the formation of vaccine fragments during the breakdown by CS.

Along with guaranteeing security and control against data loss or modification, the SDMS system works to automatically collect all relevant lab-generated data for use by laboratory staff.